top of page
2023
2022
Nov 30 - Dec 1, 2022
Ridgeline Presented at the 6th Obesity & NASH Drug Development Summit
Dec 7-8, 2022
Ridgeline Therapeutics was Represented in a Panel Discussion on Optimizing Trial Success with Your CRO: Relationship, Management, and Development at the Outsourcing in Clinical Trials Texas Conference
Sep 28-29, 2022
Ridgeline Therapeutics Presented at the Longevity Investors Conference
Sep 26-29, 2022
Ridgeline Therapeutics Presented at the Defense Tech Connect Conference
June 13-16, 2022
Ridgeline Therapeutics presented at BIO International Convention as an NIH-Sponsored showcase at the Innovation Zone and on the Innovation Stage, which highlighted companies with cutting-edge work
April 28-30, 2022
Ridgeline Therapeutics Presented at the 3rd International Conference on Fatty Liver
Mar 23-25, 2022
Ridgeline Therapeutics Team Members Participated in the Geroscience Task Force on the Challenge in Developing Geroscience Drug Trials at the Annual Euro-Geroscience Conference
Feb 24, 2022
Ridgeline Therapeutics Presented at the Annual Texas Life Science Forum
2021
2020
Apr 21-22, 2020
Ridgeline Therapeutics Selected as One of 10 Emerging Companies for the Biotech Showcase at the Longevity Leaders World Congress
2019
Sep 11-12, 2019
Ridgeline Therapeutics Presented at the Outsourcing in Clinical Trials Texas Conference
Jan 6-9, 2019
Ridgeline Therapeutics Presented at the Biotech Showcase, an Exclusive Investor Conference Held in San Francisco Alongside J.P. Morgan Healthcare 2019
2018
Nov, 2018
Ridgeline Therapeutics Presented in the U.S.-China Innovation and Investment Summit Grand Finals Event Jointly Sponsored by the US and Chinese Governments
Oct 5, 2018
Ridgeline Therapeutics Spoke at the Regenerative Medicine in Aging Symposium at Rice University
May 14-15, 2018
Ridgeline Therapeutics Awarded First Place at the US-China Investment and Innovation Summit
2017
bottom of page